Purity assessment by SDS-PAGE

0.5 μg of Human Anti-IL6R Antibody, MCA6106 (tocilizumab biosimilar, research grade) and tocilizumab (therapeutic reference product) were denatured and analyzed under reducing (R) and non-reducing (NR) conditions. Bands were visualized using Coomassie staining. Full IgG (H2L2), heavy (H) and light chains (L) are indicated.

Purity assessment by SDS-PAGE

0.5 μg of Human Anti-IL6R Antibody, MCA6106 (tocilizumab biosimilar, research grade) and tocilizumab (therapeutic reference product) were denatured and analyzed under reducing (R) and non-reducing (NR) conditions. Bands were visualized using Coomassie staining. Full IgG (H2L2), heavy (H) and light chains (L) are indicated.